ZBeats says FDA cleared ZBPro to analyze ECG recordings up to 14 days

Bin Fang and Peng Zhang are widening ZBeats beyond short Holter studies as they pursue a hardware-neutral layer for cardiac diagnostics.

By · Published

Primary source: PR Newswire

Why it matters

ZBeats can now pursue longer patch studies as well as Holter data, widening its market. Interoperability and workflow economics will determine whether its independent software layer wins deployments.

Hands interact with a modern touchscreen monitor displaying complex ECG waveforms and data analysis in a medical setting.

ZBeats, the Stony Brook ECG software developer founded by Bin Fang and Peng Zhang, said on September 15th that the Food and Drug Administration granted 510(k) clearance K261580 for ZBPro Diagnostic v2.0, expanding the software to recordings ranging from one minute to 14 days.…

When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.

Reader comments

Conversation for this story loads after sign-in.